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THE FUTURE IS NOW: A VOLUNTARY GAMETE DONOR
REGISTRY IS FEASIBLE
Nanette R. Elster, JD, MPH
Andrea Braverman, Ph.D.
On March 28, 2008, the Health Law Institute at DePaul University
College of Law co-sponsored a one-day symposium entitled, "Tracking
Change: The Feasibility of a Voluntary Gamete Donor Registry in the
United States." The symposium was a gathering of professionals from
a range of disciplines working in the field of assisted reproductive
technology (ART). Attorneys, reproductive endocrinologists, medical
directors of sperm banks, mental health professionals, and information
technology experts convened to discuss where a need for a gamete
donor registry exists, what issues a registry must take into account from
the perspective of the myriad stakeholders impacted and what the risks
and benefits of such an undertaking might be.
Summarizing this first of its kind national meeting in one short
essay is a difficult task. What makes this task even more daunting is to
summarize the genesis of this meeting - the many months of discussion
that culminated in this one day event that brought together groups of
individuals that at times have been at odds regarding this particular
topic. The issue of collection, storage, and dissemination of genetic,
medical, mental health, and social information about gamete donors
and their offspring has been rife with controversy.1 In recent years,
however, as the use of donor gametes has increased,2 children of
gamete donation have come of age, 3 and genetic medicine is no longer
just the wave of the future,4 the topic has been more in the fore
nationally and internationally.
1 See, e.g., Johnson v. Superior Court, 80 Cal. App. 4th 1050; 95 Cal. Rptr. 2d 864
(2000) (Parents of a child affected with a genetic condition sought to depose an
anonymous sperm donor); Denise Grady, "As the Use of Donor Sperm Increases,
Secrecy Can Be a Health Hazard," The New York Times, June 6, 2006 at 5.
2 CDC, "2005 Assisted Reproductive Technology (ART) Report," 2007 ( The number
of cycles using donated eggs was 16,661 in 2005, this is up significantly from over a
decade ago when just over 5,000 cylces were reported using donor egg, CDC, "1996
Assisted Reproductive Technology Success Rates," (1998)).
3 See, e.g., Scott Harris, "Families on the Cusp of an Uncharted Realm;
Relationships* As They Approach 18, the Children of Women who Patronized a
Pioneering Sperm Bank Face the Choice of Learning Donor Fathers' Identities," Los
Angeles Times, May 3, 2002 at Part 5, Page 1.
4 See, e.g., Human Genome Project Information, "Medicine and the New Genetics,"
at http://www.ornl.gov/sci/techresources/HumanGenome/medicine/medicine.shtml
last visited on June 2, 2008.
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In October 2006 the authors of this essay reminisced about an
educational panel we had both participated in four years earlier
regarding disclosure of gamete donor information. We marveled at
how timely such a topic had become in four short years. Our
reminiscing soon turned to brainstorming as we contemplated how to
revitalize this discussion among the many disciplines working in ART.
In just a few hours we had developed a list of sixty or more
professionals from a full range of disciplines whom we believed would
contribute greatly to a discussion of what information about gamete
donors, their offspring and the recipients should be collected, stored,
and maintained and under what circumstances. Our next task was to
decide what to do with this list.
Despite the vast expertise we had identified, we needed a
structure or a framework to bring this group together for a productive
discussion of the issues. Our central question being: Is a gamete donor
registry even feasible? We soon concluded that the question was too
big for us to answer and thus a roundtable discussion would be a
productive way to measure the interest in a donor registry, identify the
potential pitfalls; concerns and benefits. With no funding nor any
formal organizational support we reached out to the sixty individuals
we identified and invited them to attend a half day discussion which
would proceed the 2007 Annual Meeting of the American Society for
Reproductive Medicine. To our great amazement, over half of the
invitees attended and nearly all the invitees expressed great interest in
the discussion.
The meeting, as anticipated, generated far more questions than
answers, however, one thing became very clear - interest was piqued.
All involved believed that examining the feasibility of a gamete donor
registry was vital, however, no one was quite willing to take a next
step. As the meeting concluded, attendees turned to these authors
posing the question "What's next?" And, thus the idea for the
"Tracking Change" symposium was born.
Recently, concerns about secrecy in the use of donor gametes
have led to regulatory responses in a number of European nations and
Australia.5  The United States, greatly concerned with potential
infringement on reproductive rights and privacy, however, continues to
5 See, e.g., Janssens, et. al., "A New Dutch Law Regulating Provision of Identifying
Information of Donors to Offspring: Background, Content and Impact," 21 Human
Reproduction 852-856 (2006), Human Fertilisation and Embryology Authority,
Statutory Instrument 2004 No. 1511, "The Human Fertilisation and Embryology
Authority (Disclosure of Donor Information) Regulations 2004
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take a somewhat laissez faire approach with piecemeal solutions being
implemented by individual sperm banks 6 or consumer groups such as
the Donor Sibling Registry7 and the Single Mother's by Choice Sibling
Registry8 and for-profit entities such as "Genetisafe" 9 which seek, for a
fee, to keep gamete recipients up to date on significant health
conditions of the donor. These lay registries have emerged without
public discourse, public accountability, multidisciplinary expertise,
uniformity or oversight or any other enforcement mechanism.
Additionally, legislative proposals have begin to emerge in the United
States' ° , and thus the time had come for those professionals most
directly impacted by the collection, storage and dissemination of such
information to take the lead in the discussion and develop a solution
that is feasible; acceptable to donors, recipients and offspring alike; and
is cost effective and not unduly burdensome. Such a solution
necessitates consideration of the implications for all stakeholders such
as privacy and confidentiality including compliance with the Health
Insurance Portability and Accountability Act (HIPAA), reproductive
freedom, and children's rights.
Creation of a centralized, voluntary gamete donor registry is
one mechanism that could facilitate collection and maintenance of
pertinent medical, health and genetic information; may help avoid
identity issues or familial disconnect experienced by some children
born as a result of gamete donation; would be useful in avoiding
inadvertent consanguinity and enable offspring to make more informed
reproductive decisions; would enable ART programs to share
information with one another about donors; would ensure that donors
do not participate in multiple programs and more times than is
medically recommended; and could facilitate
outcomes/epidemiological research which is currently lacking despite,
the thousands of birth annually in the U.S. utilizing donated gametes.
The Tracking Change symposia examined the feasibility of
taking a multi-disciplinary approach to developing a registry, including
practical, theoretical and ethical benefits and barriers with a particular
6 See, e.g. California Cryobank at
http://www.cryobank.con/siblingregistry2/faqs1.cfm
7 The Donor Sibling Registry at http://www.donorsiblingregistry.coml last visited
June2, 2008.
8 Single Mother's by Choice Sibling Registry at
http://www.singlemothersbychoice.com/sibling.html last visited June 2, 2008.
9 "Genetisafe," at http://www.genetisafe.com/ last visited June 2, 2008.
10 Virginia HB412 "Gamete donors; anonymous donations thereof prohibited in
medical procedures," Introduced January 2006.
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focus on the legal and policy considerations necessary to its
implementation, acceptance, and effectiveness. These considerations
were discussed from the perspectives of the range of stakeholders:
physicians; fertility centers/sperm banks; recipients of donor gametes;
donors; mental health professionals who work with recipients, donors
and offspring of donor gametes; and society. One issue became
abundantly clear throughout the day. . . to develop an effective registry
requires a balancing of interests of the child, donor, intended parents,
health care professionals, and society in addition to a risk/benefit
analysis in an effort to protect, promote and enhance this important
reproductive option and ensure the physical and emotional safety and
privacy of all participants including the resultant offspring.
What follows is a detailed outline of the most salient issues that
should be considered in the development and implementation of any
gamete donor registry in the United States.
Overarching Issues
A. Need for a registry
SNo
" Yes: Voluntary or Mandatory
B. Appropriate information to the collected regarding:
SDonor
" Offspring
" Intended parents
C. Length of time information remains available
D. Function of the registry
SProvide information
1. Offspring
2. Medical professionals
3. Parents
4. Donors
5. Researchers
Medical Considerations
> FDA concerns
> Safety
> Recipient
> Donor
> Offspring
> Practicality
> Cost
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> Logistics
Mental Health/Psychosocial Issues
> Offspring
> Donors
> Donors' offspring
> Recipients
Ethical Issues
A. Expectations - (Autonomy/Justice)
> Donors
> Recipients
> Medical professionals
B. Obligations of and Obligations to - (Beneficence/Justice)
> Offspring
> Donors
> Donors' offspring
> Medical Professionals
Recipients
Legal Considerations
A. Privacy/Confidentiality
> Access
Information Available
Information Disclosure
B. Other Constitutional Law Issues
a. Procreative Liberty
b. Right to care, control and upbringing of child
C. Type of Liability of impacted party(ies) Responsible
party(ies)
a. RE/Fertility Center
b. Donor Agency
c. Sperm Bank
d. Other
Logistics Considerations
A. Information System
> Privacy protections
> Design
) Hosting party(ies)
B. Cost
C. Uniformity
D. Administration
> Data collection
> Maintenance
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Disclosure
This one day symposium touched on most if not all of these
issues, and as the day came to a close, it became clear that most
speakers were in agreement that the first question of this outline should
be answered in the affirmative -- a voluntary registry is very important.
The reasons such a registry is significant are manifold, including
medical considerations for donors, donor's children, offspring, and
offspring's children; psychological considerations; ethical concerns
and, even political motivation in the sense that self regulation may be
more effective and efficient than reactive legislation. Creation of a
registry would enable the industry, long shrouded in secrecy to become
more transparent and more accountable which may ultimately lead to
eradication of the stigma so long associated with gamete donation.
Another reason for the importance of a registry is akin to many
other kinds of registries that exist in the public health sphere such as
tumor registries or other disease specific registries. A registry could
promote progress, quality assurance, and protection of
patient/participant safety, through surveillance and empirical research,
two areas currently lacking in ART.
Participants made it clear, though, that if any registry were to
exist the flow of information maintained would need to multi-
directional. Thus, a registry would encompass more than just
information flow to offspring. Information might flow between medical
centers, from offspring to donors, etc. From an ethical perspective, this
is one means of fairly distributing the benefits and the burdens and
attempting to balance the autonomy of all stakeholders.
Another factor raised for consideration was the flexibility and
fluidity of the structure and implementation of a registry. As the
technology changes, so too do the issues that must be considered and
the information that is available. For example, the ability to freeze and
bank eggs as we currently do sperm, looms on the horizon,' 1 how or
should this impact any existing registry? How does the function of a
registry change if the time comes and we all carry genetic identification
cards? These are only some of the future considerations that must be
taken into account in developing a registry that will be functional over
time.
11 See, e.g., Chang, Ching Chien, "Two Successful Pregnancies Obtained Following
Oocyte Vitrification and Embryo Re-Vitrification," 16 Reproductive BioMedicine
Online 346-349 (January 2008).
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What became most obvious during the course of the day,
however, is that this is a tremendously complex issue, but its
complexity is no reason to avoid or ignore it. The mere free flow of
information and discussion throughout the symposium suggested that a
voluntary registry is more likely to expand rather than limit the options
of all whose live may be impacted by gamete donation. Even more
significant was the recognition that development of a registry is not
synonymous with eliminating anonymity in gamete donation. The
collection, storage and dissemination of information does not
necessitate revelation of identities unless all participants involved agree
to such openness. The decision of when, what, how and to whom to
disclose information of such a personal nature is highly personal and to
some may be tantamount to a secret, but that does not and should not
equate with negativity so often attributed to the word "secret." Ethicist
Sissela Bok captures the essence of this when she writes: "While all
deception requires secrecy, all secrecy is not meant to deceive." 
12
12 Sissela Bok, Secrets: On the Ethics of Concealment and Revelation, Pantheon
1982.
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